Novel compounds of the formula I
in which
D, W, X, Y, T and R
1
are as defined in patent Claim
1,
are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
式子I中的新化合物,其中D、W、X、Y、T和R1如专利权利要求书中所定义,是
凝血因子Xa的
抑制剂,可用于预防和/或治疗血栓性疾病和肿瘤治疗。